Nouvelle déclaration d'incident
No de la demande: 2010-3408
Numéro de référence du titulaire d'homologation: 640951
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer CropScience Inc.
Adresse: #200, 160 Quarry Park Blvd SE
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2C 3G3
Incident chez l'humain
Pays: UNITED STATES
État: TEXAS
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Tempo (Bayer CropScience)
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Triumph Insecticide (Syngenta)
Liquide
Non
Inconnu
Professionnel de la santé
Sexe: Femme
Âge: >1 <=6 yrs / > 1 < = 6 ans
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Non professionnel
Empoisonnement par ingestion d'un produit
Aucun
Orale
<=15 min / <=15 min
<=30 min / <=30 min
6/2/2010 Caller is a poison information specialist calling from a poison control center regarding a two year old child that drank a liquid thinking it was lemonade on 5/29/2010. This liquid had been inappropriately stored in a plastic squeeze water bottle. Apparently, a neighbor of the patient's parents have given the parents the plastic bottle containing one or two kinds of insecticides. Despite several follow-up calls with the treating hospital and a local public poison center in (State), no one has been able to confirm the contents of this bottle, although Tempo insecticide containing the pyrethroid cyfluthrin or Triumph Insecticide containing the organophosphate Isazofos were implicated. Tempo is a brand name owned by Bayer CropScience. Triumph Insecticide containing Isazofos was formally made by Syngenta. The patients' clinical course was marked by the rapid onset of vomiting, increased bronchial secretions, lacrimation, and salivation making the likely offending agent the Isazofos in the Triumph Insecticide. The child was treated with atropine at the local hospital, and became unresponsive. The child was intubated and flown to another hospital where she was treated with 2-PAM and remains on a ventilator. The initial symptoms of excess secretions resolved within the first 24 hours, though she continues to have respiratory compromise. The board certified medical toxicologist from the poison center completed a phone consultation with the child's treatment team, but no board certified medical toxicologist has seen the child at the hospital. Acetyl cholinesterase levels were recommended by the toxicologist with the consultation, but it is not clear if these labs have been drawn or what the results were. 6/3/2010 Callback to the poison center for follow up information. The child's condition has not changed since yesterday. A chest x-ray done this morning shows bilateral lung infiltrates and atelectasis. Thoracic physical therapy has been initiated to help with lung function. They are hoping to begin to wean her off of the ventilator tomorrow. 6/7/2010 Callback to the poison center for follow up information. The child remains on a ventilator, though is largely stable. Her vital signs and lab work are essentially normal. They attempted to extubate her on 6/4/2010 and 6/5/2010 without success. She would begin to develop respiratory distress within about 60 minutes of extubation, and was intubated again. Her lungs have coarse rales throughout and there is some evidence of scarring of the vocal cords according to the hospital. An ear, nose, and throat specialist will see the child in the next day or so prior to additional attempts to extubate. 6/9/2010 Callback to the treating hospital for follow up information. The child remains on a ventilator at this time, and continues to have ongoing respiratory issues as previously noted. Ear, nose, and throat specialist has not been in to see the child, and the consultation has been held until she is off of the ventilator.
Majeure